Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction

医学 氯吡格雷 经皮冠状动脉介入治疗 内科学 心肌梗塞 阿司匹林 置信区间 急性冠脉综合征 血运重建 指南 血管紧张素受体阻滞剂 传统PCI 心脏病学 血管紧张素转换酶 血压 病理
作者
Tomas Jernberg,Per Johanson,Claes Held,Bodil Svennblad,Johan Lindbäck,Lars Wallentin
出处
期刊:JAMA [American Medical Association]
卷期号:305 (16): 1677-1677 被引量:384
标识
DOI:10.1001/jama.2011.522
摘要

Only limited information is available on the speed of implementation of new evidence-based and guideline-recommended treatments and its association with survival in real life health care of patients with ST-elevation myocardial infarction (STEMI).To describe the adoption of new treatments and the related chances of short- and long-term survival in consecutive patients with STEMI in a single country over a 12-year period.The Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA) records baseline characteristics, treatments, and outcome of consecutive patients with acute coronary syndrome admitted to almost all hospitals in Sweden. This study includes 61,238 patients with a first-time diagnosis of STEMI between 1996 and 2007.Estimated and crude proportions of patients treated with different medications and invasive procedures and mortality over time.Of evidence-based treatments, reperfusion increased from 66% (95%, confidence interval [CI], 52%-79%) to 79% (95% CI, 69%-89%; P < .001), primary percutaneous coronary intervention from 12% (95% CI, 11%-14%) to 61% (95% CI, 45%-77%; P < .001), and revascularization from 10% (96% CI, 6%-14%) to 84% (95% CI, 73%-95%; P < .001). The use of aspirin, clopidogrel, β-blockers, statins, and angiotensin-converting enzyme (ACE) inhibitors all increased: clopidogrel from 0% to 82% (95% CI, 69%-95%; P < .001), statins from 23% (95% CI, 12%-33%) to 83% (95% CI, 75%-91%; P < .001), and ACE inhibitor or angiotensin II receptor blockers from 39% (95% CI, 26%-52%) to 69% (95% CI, 58%-70%; P < .001). The estimated in-hospital, 30-day and 1-year mortality decreased from 12.5% (95% CI, 4.3%-20.6%) to 7.2% (95% CI, 1.7%-12.6%; P < .001); from 15.0% (95% CI, 6.2%-23.7%) to 8.6% (95% CI, 2.7%-14.5%; P < .001); and from 21.0% (95% CI, 11.0%-30.9%) to 13.3% (95% CI, 6.0%-20.4%; P < .001), respectively. After adjustment, there was still a consistent trend with lower standardized mortality over the years. The 12-year survival analyses showed that the decrease of mortality was sustained over time.In a Swedish registry of patients with STEMI, between 1996 and 2007, there was an increase in the prevalence of evidence-based treatments. During this same time, there was a decrease in 30-day and 1-year mortality that was sustained during long-term follow-up.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
杨岱溪发布了新的文献求助10
刚刚
刚刚
刚刚
刚刚
xu发布了新的文献求助10
刚刚
刚刚
所所的应助被大聪明玩家888采纳,获得10
1秒前
锈了的xuebxuebi雪碧完成签到,获得积分10
1秒前
xu发布了新的文献求助10
1秒前
Haj1mi完成签到,获得积分10
2秒前
2秒前
2秒前
xu发布了新的文献求助10
2秒前
华生完成签到,获得积分10
2秒前
xu发布了新的文献求助10
2秒前
2秒前
健忘的日记本完成签到 ,获得积分10
2秒前
2秒前
2秒前
xu发布了新的文献求助10
3秒前
lgn完成签到,获得积分10
3秒前
3秒前
慕青的应助被天高路远采纳,获得10
3秒前
3秒前
3秒前
搞科研啊发布了新的文献求助10
4秒前
4秒前
xu发布了新的文献求助10
4秒前
4秒前
森一发布了新的文献求助10
4秒前
BurgerKing完成签到,获得积分10
5秒前
5秒前
xu发布了新的文献求助10
5秒前
科研通AI6.2的应助被cesc采纳,获得10
5秒前
阿莫仙完成签到,获得积分10
5秒前
爱笑半雪完成签到,获得积分10
5秒前
5秒前
xiaoyan发布了新的文献求助10
5秒前
xu发布了新的文献求助10
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8174559
求助须知:如何正确求助?哪些是违规求助? 9566586
关于积分的说明 21787112
捐赠科研通 7768831
什么是DOI,文献DOI怎么找? 3431746
关于科研通互助平台的介绍 2555956
邀请新用户注册赠送积分活动 2477100